Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Biological Diversity of Histologic Subtypes

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.

    Article  Google Scholar 

  2. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.

    Article  Google Scholar 

  3. Fisher ER, Anderson S, Redmond C, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06. 10-year pathologic and clinical prognostic discriminants. Cancer. 1993;71:2507–14.

    Article  CAS  PubMed  Google Scholar 

  4. Hassett MJ, Silver SM, Hughes ME, Blayney DW, Edge SB, Herman JG, et al. Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer. J Clin Oncol. 2012;30:2218–26.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Tadros AB, Wen HY, Morrow M. Breast cancers of special histologic subtypes are biologically diverse. Ann Surg Oncol. 2018;25:3158–64.

    Article  PubMed  Google Scholar 

  6. Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, et al. Prospective validation of a 21-gene expression assay in breast cancer. N Engl J Med. 2015;373:2005–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Meric-Bernstam F, Johnson A, Holla V, Bailey AM, Brusco L, Chen K, et al. A decision support framework for genomically informed investigational cancer therapy. J Natl Cancer Inst. 2015;107(7):djv098.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Afghahi A, Sledge GW Jr. Targeted therapy for cancer in the genomic era. Cancer J. 2015;21:294–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

The preparation of this commentary was funded in part by NIH/NCI Cancer Center Support Grant No. P30 CA008748 to Memorial Sloan Kettering Cancer Center.

Author information

Authors and Affiliations

  1. Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Audree B. Tadros MD, MPH & Monica Morrow MD

Authors
  1. Audree B. Tadros MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Monica Morrow MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Monica Morrow MD.

Ethics declarations

Disclosure

Dr. Monica Morrow has received honoraria from Genomic Health and Roche.

Additional information

ASO Author Reflections is a brief invited commentary on the article, Breast Cancers of Special Histologic Subtypes Are Biologically Diverse. Ann Surg Oncol. 2018;25:3158–64.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tadros, A.B., Morrow, M. ASO Author Reflections: Biological Diversity of Histologic Subtypes. Ann Surg Oncol 25 (Suppl 3), 636–637 (2018). https://doi.org/10.1245/s10434-018-6846-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-018-6846-2

Keywords

Search

Navigation